Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Enrolling by invitation × Myasthenia Gravis × Clear all

Phase

Phase 3 2 Phase 2/3 1

Status

Recruiting 7 Unknown 2 Withdrawn 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphedema 1 Leukemia, Promyelocytic, Acute 1 Cholangiocarcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05374590 2026-02-02

ADAPT Jr +

argenx

Phase 2/3 Enrolling by invitation

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡